486 related articles for article (PubMed ID: 30742783)
21. Molecular Mechanisms of Kidney Injury and Repair.
Rayego-Mateos S; Marquez-Expósito L; Rodrigues-Diez R; Sanz AB; Guiteras R; Doladé N; Rubio-Soto I; Manonelles A; Codina S; Ortiz A; Cruzado JM; Ruiz-Ortega M; Sola A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163470
[TBL] [Abstract][Full Text] [Related]
22. Kidney injury molecule-1 in kidney disease.
Yin C; Wang N
Ren Fail; 2016 Nov; 38(10):1567-1573. PubMed ID: 27758121
[TBL] [Abstract][Full Text] [Related]
23. Advanced Approaches Based on Expression of Different Genes and Biomarkers for the Diagnosis and Treatment of Renal Disorders.
Sharma M; Pandey V; Sharma CK
Crit Rev Eukaryot Gene Expr; 2019; 29(4):319-332. PubMed ID: 31679293
[TBL] [Abstract][Full Text] [Related]
24. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
[TBL] [Abstract][Full Text] [Related]
25. PGC1α in the kidney.
Lynch MR; Tran MT; Parikh SM
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F1-F8. PubMed ID: 28931521
[TBL] [Abstract][Full Text] [Related]
26. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
Sinna MM; Altaf FMN; Mosa OF
Curr Pharm Des; 2019; 25(10):1122-1133. PubMed ID: 31096894
[TBL] [Abstract][Full Text] [Related]
27. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
[TBL] [Abstract][Full Text] [Related]
28. Iron metabolism in the pathogenesis of iron-induced kidney injury.
Martines AM; Masereeuw R; Tjalsma H; Hoenderop JG; Wetzels JF; Swinkels DW
Nat Rev Nephrol; 2013 Jul; 9(7):385-98. PubMed ID: 23670084
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis, epidemiology and outcomes of acute kidney injury.
Waikar SS; Liu KD; Chertow GM
Clin J Am Soc Nephrol; 2008 May; 3(3):844-61. PubMed ID: 18337550
[TBL] [Abstract][Full Text] [Related]
30. L-FABP: A novel biomarker of kidney disease.
Xu Y; Xie Y; Shao X; Ni Z; Mou S
Clin Chim Acta; 2015 May; 445():85-90. PubMed ID: 25797895
[TBL] [Abstract][Full Text] [Related]
31. [Acute kidney injury: a current comprehensive overview].
Sotak Š
Vnitr Lek; 2017; 63(2):93-97. PubMed ID: 28334540
[TBL] [Abstract][Full Text] [Related]
32. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease.
Shu S; Zhu J; Liu Z; Tang C; Cai J; Dong Z
EBioMedicine; 2018 Nov; 37():269-280. PubMed ID: 30314894
[TBL] [Abstract][Full Text] [Related]
33. Extracellular vesicles in diagnosis and therapy of kidney diseases.
Zhang W; Zhou X; Zhang H; Yao Q; Liu Y; Dong Z
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F844-F851. PubMed ID: 27582107
[TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanisms of the Acute Kidney Injury to Chronic Kidney Disease Transition: An Updated View.
Guzzi F; Cirillo L; Roperto RM; Romagnani P; Lazzeri E
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590461
[TBL] [Abstract][Full Text] [Related]
35. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
36. N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
Small DM; Sanchez WY; Roy SF; Morais C; Brooks HL; Coombes JS; Johnson DW; Gobe GC
Am J Physiol Renal Physiol; 2018 May; 314(5):F956-F968. PubMed ID: 29357409
[TBL] [Abstract][Full Text] [Related]
37. Predicting progression to chronic kidney disease after recovery from acute kidney injury.
Heung M; Chawla LS
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):628-34. PubMed ID: 23010757
[TBL] [Abstract][Full Text] [Related]
38. Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers.
Gyurászová M; Gurecká R; Bábíčková J; Tóthová Ľ
Oxid Med Cell Longev; 2020; 2020():5478708. PubMed ID: 32082479
[TBL] [Abstract][Full Text] [Related]
39. Clinical Application of Kidney Biomarkers in Cirrhosis.
Allegretti AS; Solà E; Ginès P
Am J Kidney Dis; 2020 Nov; 76(5):710-719. PubMed ID: 32622560
[TBL] [Abstract][Full Text] [Related]
40. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
